Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment

This study has been terminated.
(Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made.)
Sponsor:
Information provided by (Responsible Party):
Diethelm Tschoepe, Ruhr University of Bochum
ClinicalTrials.gov Identifier:
NCT01199783
First received: April 29, 2010
Last updated: May 4, 2015
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)